Quéméneur Thomas, Mouthon Luc, Cacoub Patrice, Meyer Olivier, Michon-Pasturel Ulrique, Vanhille Philippe, Hatron Pierre-Yves, Guillevin Loïc, Hachulla Eric
From the Department of Nephrology and Internal Medicine (TQ, PV), Hospital of Valenciennes, Valenciennes; Université Paris Descartes, National Reference Centre for Scleroderma and Systemic Vasculitis (LM, LG), Cochin Hospital, Paris; Department of Internal Medicine (PC), AP-HP, Hôpital Pitié-Salpêtrière, Paris; Department of Rheumatology (OM), Bichat Hospital, Paris; Department of Vascular Medicine (UMP), Saint-Joseph Hospital, Paris; and Department of Internal Medicine, National Reference Centre for Scleroderma (PYH, EH), Claude Huriez Hospital, University of Lille, Lille, France.
Medicine (Baltimore). 2013 Jan;92(1):1-9. doi: 10.1097/MD.0b013e31827781fd.
Although the presence of antineutrophil cytoplasmic antibodies (ANCA) has been reported in patients with systemic sclerosis (SSc), the association of SSc and systemic vasculitis has rarely been described. We obtained information on cases of systemic vasculitis associated with SSc in France from the French Vasculitis Study Group and all members of the French Research Group on Systemic Sclerosis. We identified 12 patients with systemic vasculitis associated with SSc: 9 with ANCA-associated systemic vasculitis (AASV) and 3 with mixed cryoglobulinemia vasculitis (MCV). In all AASV patients, SSc was of the limited type. The main complication of SSc was pulmonary fibrosis. Only 2 patients underwent a D-penicillamine regimen before the occurrence of AASV. The characteristics of AASV were microscopic polyangiitis (n = 7) and renal limited vasculitis (n = 2). Anti-myeloperoxidase antibodies were found in 8 of the 9 patients. The Five Factor Score was above 1 in 3 of the 9 patients. Of the 3 patients with MCV, Sjögren syndrome was confirmed in 2. We compared our findings with the results of a literature review (42 previously reported cases of AASV with SSc). Although rare, vasculitis is a complication of SSc. AASV is the most frequent type, and its diagnosis can be challenging when the kidney is injured. Better awareness of this rare association could facilitate earlier diagnosis and appropriate management to reduce damage.
尽管在系统性硬化症(SSc)患者中已报道存在抗中性粒细胞胞浆抗体(ANCA),但SSc与系统性血管炎的关联却鲜有描述。我们从法国血管炎研究小组和法国系统性硬化症研究小组的所有成员处获取了法国SSc相关系统性血管炎病例的信息。我们确定了12例与SSc相关的系统性血管炎患者:9例为ANCA相关系统性血管炎(AASV),3例为混合性冷球蛋白血症血管炎(MCV)。在所有AASV患者中,SSc为局限性类型。SSc的主要并发症是肺纤维化。只有2例患者在AASV发生前接受了青霉胺治疗方案。AASV的特征为显微镜下多血管炎(n = 7)和肾脏局限性血管炎(n = 2)。9例患者中有8例检测到抗髓过氧化物酶抗体。9例患者中有3例的五因素评分高于1。在3例MCV患者中,2例确诊为干燥综合征。我们将我们的研究结果与文献综述(42例先前报道的SSc合并AASV病例)的结果进行了比较。血管炎虽然罕见,但却是SSc的一种并发症。AASV是最常见的类型,当肾脏受损时其诊断可能具有挑战性。更好地认识这种罕见关联有助于早期诊断和适当管理以减少损害。